About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT03535558

Fluoroquinolone Associated Disability

The purpose of this study is to: 1) describe drug utilization for Fluoroquinolone(FQ), Azithromycin (AZ) and Sulfamethoxazole/Trimethoprim(ST) in the entire Truven MarketScan Commercial Claims and Enc...

Lead sponsor: Janssen Research & Development, LLC•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Janssen Research & Development, LLC

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Participants in the Truven CCAE database who were eligible for disability insurance and can be linked to the Truven Health and Productivity Management (HPM) database
•Study participants will be included if they have 6 months of history before the first day on FQ or AZ/ST and at least 120 days afterward

Exclusion Criteria

•If any protocol specified medical conditions or exposure to the protocol specified medications in the 6 months preceding the first qualifying dose of FQ or AZ/ST
•If participants have any disability claim in the 6 months preceding the qualifying FQ or AZ/ST dose
•If participants have the protocol specified condition-specific diagnoses within the 3 months preceding the qualifying FQ or AZ/ST exposure

Related studies

Antibiotic Irrigation and Suction Ureteral Access Sheath in RIRS

NCT07655050 · Kidney Calculi, Urolithiasis, and more

RECRUITINGPhase 3

A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

NCT06338995 · Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

RhinAV_Evaluation of Treatments for Acute Viral Rhinitis, Rhinosinusitis, and Rhinopharyngitis

NCT07383493 · Rhinitis Acute, Rhinitis Viral, and more

Double Voiding and Post-transplant UTI

NCT05711446 · Urinary Tract Infections, Kidney Transplant; Complications

RECRUITINGPhase 2

Antibiotic Prophylaxis for Neurogenic Bladder Botox

NCT04791579 · Neurogenic Bladder, Post-operative Urinary Tract Infections

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 29, 2019Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment239,306

Start dateMay 2018

Last updatedJan 29, 2019

Condition

Bronchitis Sinusitis Urinary Tract Infections

Locations shown

Janssen Investigative Site

Titusville, New Jersey

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 29, 2019Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions